Literature DB >> 12029411

Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.

Louis Bont1, Jan L L Kimpen.   

Abstract

Respiratory syncytial virus (RSV) bronchiolitis resulting in respiratory insufficiency is frequently encountered during the winter season in paediatric intensive care units. This review evaluates potential determinants described in severe RSV bronchiolitis with special attention to the role of immaturity of immune responses during infancy. Pre-existent cardiac or pulmonary compromises have been documented as clinical risk factors for severe RSV bronchiolitis. In addition to this group of infants with pre-morbidity, a large proportion of mechanically ventilated RSV bronchiolitis patients are previously healthy full-term infants or premature neonates without predisposing risk factors. In general, infants at this early age have maturation-related deficient cellular immunity. Several studies show an association between decreased cellular immunity and severe RSV bronchiolitis, indeed suggesting that a maturation-related defect of the cellular immune system facilitates severe RSV. In addition, low virus-specific antibody titres prior to RSV bronchiolitis have been shown to be a risk factor for severe RSV bronchiolitis. A low level of cellular and humoral immunity would explain that higher viral titres are found in infants with most severe illness. In conclusion, immaturity of the physiological functions in healthy pre-term infants and neonates, in particular the immune system, appears to be an important factor in the pathogenesis of RSV bronchiolitis resulting in mechanical ventilation.

Entities:  

Mesh:

Year:  2002        PMID: 12029411     DOI: 10.1007/s00134-002-1256-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  11 in total

1.  Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants.

Authors:  Marisa M Mussi-Pinhata; Fabrizio Motta; Laura Freimanis-Hance; Ricardo de Souza; Edgardo Szyld; Regina C M Succi; Celia D C Christie; Maria J Rolon; Mariana Ceriotto; Jennifer S Read
Journal:  Int J Infect Dis       Date:  2010-05-08       Impact factor: 3.623

Review 2.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 3.  Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

Authors:  X Carbonell-Estrany; L Bont; G Doering; J-B Gouyon; M Lanari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-16       Impact factor: 3.267

4.  The use of C-reactive protein in predicting bacterial co-Infection in children with bronchiolitis.

Authors:  Mohamad Fares; Sawsan Mourad; Mariam Rajab; Nahida Rifai
Journal:  N Am J Med Sci       Date:  2011-03

5.  Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis.

Authors:  Hans-Olav Fjaerli; Geir Bukholm; Anne Krog; Camilla Skjaeret; Marit Holden; Britt Nakstad
Journal:  BMC Infect Dis       Date:  2006-12-13       Impact factor: 3.090

Review 6.  Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus.

Authors:  Silvia Vandini; Paolo Bottau; Giacomo Faldella; Marcello Lanari
Journal:  Biomed Res Int       Date:  2015-05-06       Impact factor: 3.411

Review 7.  Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.

Authors:  Bernhard Resch
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

8.  WU polyomavirus detected in children with severe respiratory failure.

Authors:  Kazuhiro Uda; Chitose Koyama-Wakai; Kensuke Shoji; Noriyasu Iwase; Daisuke Motooka; Shota Nakamura; Isao Miyairi
Journal:  J Clin Virol       Date:  2018-08-09       Impact factor: 3.168

9.  Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community.

Authors:  M L Houben; F E J Coenjaerts; J W A Rossen; M E Belderbos; R W Hofland; J L L Kimpen; L Bont
Journal:  J Med Virol       Date:  2010-07       Impact factor: 2.327

Review 10.  Virus infections, wheeze and asthma.

Authors:  Nicola M Wilson
Journal:  Paediatr Respir Rev       Date:  2003-09       Impact factor: 2.726

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.